The KEGG database indicates that SMAD5 is closely associated with the TGF-β signaling pathway (map04350), which is considered to be one of the key pathways in the regulation of NPC progression (17–19). The gene discussed is TGFB1; the disease is nasopharyngeal carcinoma.